Franklin Resources’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Franklin Resources’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-57,307	Closed	-$12.4M	–	1537
2017 Q1	$12.4M	Hold	57,307	–	–	0.01%	909
2016 Q4	$5.3M	Hold	57,307	–	–	﹤0.01%	1076
2016 Q3	$7.75M	Hold	57,307	–	–	﹤0.01%	1024
2016 Q2	$5.81M	Hold	57,307	–	–	﹤0.01%	1078
2016 Q1	$9.39M	Hold	57,307	–	–	0.01%	996
2015 Q4	$18.8M	Hold	57,307	–	–	0.01%	852
2015 Q3	$18.5M	Sell	57,307 -7,255	-11%	-$3.19M	0.01%	869
2015 Q2	$25.7M	Hold	64,562	–	–	0.01%	829
2015 Q1	$31.8M	Sell	64,562 -7,316	-10%	-$2.84M	0.01%	758
2014 Q4	$25.7M	Sell	71,878 -7,922	-10%	-$2.36M	0.01%	806
2014 Q3	$15.4M	Sell	79,800 -16,889	-17%	-$3.71M	0.01%	950
2014 Q2	$23.1M	Sell	96,689 -955	-1%	-$194K	0.01%	828
2014 Q1	$25M	Buy	97,644 +11,855	+14%	+$3.62M	0.01%	796
2013 Q4	$17M	Buy	+85,789	New	+$15.3M	0.01%	859

Other funds holding LUMO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Franklin Resources's LUMO Position: Q2 2017 in Review

Franklin Resources sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2017, closing a stake of 57,307 shares — an estimated $12.4M sold.

Franklin Resources first reported a position in LUMO in Q4 2013 and held it in 14 quarters. The position peaked at $31.8M in Q1 2015. 110 funds tracked by Wall St. Rank hold LUMO as of Q2 2017.

Franklin Resources reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
Franklin Resources sold 57,307 Lumos Pharma, Inc. Common Stock shares in Q2 2017, an estimated $12.4M.
Franklin Resources first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2013 and held it in 14 quarters.
Franklin Resources's Lumos Pharma, Inc. Common Stock position peaked at $31.8M in Q1 2015.
110 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2017.

Based on Franklin Resources's 13F filing for Q2 2017, filed 10 Aug 2017.